Viemed Healthcare Return on Equity

Viemed Healthcare (VMD) currently reports a ROE of 10.07%. That is below the Healthcare sector average of 22.01%. Use the charts on this page to explore Viemed Healthcare's ROE history and peer comparisons.

Viemed Healthcare's ROE of 10.07% is lower than the Healthcare sector average of 22.01%. That is roughly 54.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Viemed Healthcare's current 10.07% should be judged against Healthcare norms (sector average: 22.01%) and against VMD's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 10.07%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 22.01%. From there, open related valuation or income-statement pages for Viemed Healthcare, and consider following VMD for alerts when major investors trade the stock.

Viemed Healthcare is classified in the Healthcare sector. On ROE, it currently shows 10.07% versus a sector average near 22.01%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing VMD with unrelated industries.